← Oncology Approval Tracker

FDA DECISION ·

Tecvayli

teclistamab-cqyv · Janssen Biotech

Traditional approvalTraditional conversionMultiple myeloma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Monotherapy for adults with relapsed or refractory multiple myeloma after at least four prior lines, including a proteasome inhibitor, an immunomodulatory drug and an anti-CD38 monoclonal antibody.

LAMPGEN ANALYSIS

Why it matters

This converts the original later-line monotherapy indication to traditional approval. The combination approved the same day has a different therapy-line threshold.

What research teams should watch

Verify exposure to all three specified drug classes. Use the monotherapy label and the correct evidence when discussing step-up dosing and safety obligations.

PRIMARY RECORDS

Sources